is reviewing operations at two of its vaccine making facilities in India and plans to let go of all employees at the plants, the company told Reuters, after it failed to win a UNICEF contract.
Sanofi India declined to comment on the number of employees who would be offered VRS. The French company has over 5,000 employees in India, according to its website. Sanofi plans to transfer the packaging of insulin and related injectible devices to another site and is currently evaluating which site will support it, the spokesperson said.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: